| Literature DB >> 27764091 |
Achraf Ammar1,2, Mouna Turki3, Hamdi Chtourou1,4, Omar Hammouda3,5, Khaled Trabelsi6, Choumous Kallel7, Osama Abdelkarim2, Anita Hoekelmann2, Mohamed Bouaziz8,9, Fatma Ayadi3, Tarak Driss5, Nizar Souissi10.
Abstract
PURPOSE: The aim of this study was to investigate the effect of natural Pomegranate juice supplementation on performance and acute and delayed responses of muscle soreness and biomarkers of muscle damage after a weightlifting training session.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27764091 PMCID: PMC5072630 DOI: 10.1371/journal.pone.0160305
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Experimental design.
NB: the pre sessions 1 and 2 values correspond to values of 48-h recovery; Weightlifting performance was calculated during both test sessions; Acute (RPE) and delayed (DOMS) perceived muscle fatigue and soreness were assessed respectively 3min and 48 after both test sessions.
Fig 2Calculated performances with PLA and natural POMj supplementations.
*:Significant differences between PLA and POMj conditions.
Fig 3RPE values using Placebo and natural POMj supplementations.
*: Significant differences between PLA and POMj conditions.
Fig 4DOMS values using PLA and natural POMj supplementations.
*: Significant differences between PLA and POMj conditions; k: Significant differences between DOMS of knee extensors and DOMS of elbow flexors.
Acute biological responses to weightlifting training sessions using natural POMj and PLA supplementations.
| Variables | Placebo | Pomegranate | Δ (POMj-PLA) in % | ANOVA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | % of change | Pre | Post | % of change | Pomegranate effect | Training effect | Interaction | ||
| 36.14±0.69 | 36.98±0.51 | +02.32% | 36.06±0.82 | 37.03±0.48 | +02.74% | +00.42% | F = 0.1, p>0.05, ηp2 = 0.01 | F = 2.1, p>0,05, ηp2 = 0.2 | ||
| 72.44±9.00 | 85.11±10.6 | +18.22% | 70.78±9.64 | 79.78±7.93 | +13.76% | -04.46% | F = 4.1, p>0.05, ηp2 = 0.3 | |||
| 12.49±0.96 | 13.67±0.35 | +09.89% | 11.59±0.37 | 12.52±0.72 | +8.08% | -01.81% | F = 1.1, p>0.05, ηp2 = 0.1 | |||
| 05.02±0.50 | 05.05±0.59 | NS | 04.80±0.41 | 04.30±0.67 | -10.59% | ——— | F = 3.1, p>0.05, ηp2 = 0.3 | F = 1.1, p>0.05, ηp2 = 0.1 | ||
| 82.00±8.26 | 83.67±9.43 | NS | 82.11±8.75 | 87.33±10.3 | +6.32% | ——— | F = 1.45, p>0.05, ηp2 = 0.1 | F = 5.2, p>0.05, ηp2 = 0.2 | ||
| 08.62±2.67 | 07.52±2.03 | -11.36% | 08.36±2.19 | 07.39±1.85 | NS | ——— | F = 1.1, p>0.05, ηp2 = 0.1 | F = 0.1, p>0.05, ηp2 = 0.01 | ||
| 05.34±2.12 | 04.87±1.86 | -07.97% | 04.83±1.90 | 04.68±1.92 | NS | ——— | F = 3.8, p>0.05, ηp2 = 0.3 | F = 1.4, p>0.05, ηp2 = 0.1 | ||
| 06.08±0.54 | 05.43±0.41 | -10.34% | 05.51±0.59 | 05.55±0.24 | NS | ——— | F = 2.14, p>0.05, ηp2 = 0.1 | |||
| 162.1±38.2 | 200.3±42.9 | +24.97% | 184.1±43.6 | 199.8±48.7 | NS | ——— | F = 1.49, p>0.05, ηp2 = 0.1 | F = 1.2, p>0.05, ηp2 = 0.1 | ||
| 342.4±42.2 | 440.3±56.2 | +28.28% | 262.1±19.6 | 311.8±21.4 | +19.53% | -8.75% | ||||
| 169.7±24.9 | 198.3±43.9 | +16.26% | 156.0±23.3 | 178.6±25.4 | +14.61% | -1.64% | F = 0.06, p>0.05, ηp2 = 0.2 | |||
| 26.11±7.61 | 30.44±9.15 | +16.59% | 23.33±5.29 | 26.22±4.14 | NS | ——— | F = 0.01, p>0.05, ηp2 = 0.01 | |||
| 72.44±13.5 | 75.67±13.8 | +04.51% | 72.78±16.4 | 72.67±14.3 | NS | ——— | F = 0.7, p>0.5, ηp2 = 0.1 | F = 3.1, p>0.05, ηp2 = 0.3 | ||
| 01.39±0.91 | 01.48±0.91 | +12.59% | 01.30±0.88 | 01.32±0.89 | NS | ——— | F = 2.6, p>0.05, ηp2 = 0.01 | F = 5.1, p>0.05, ηp2 = 0.4 | F = 2.5, p>0.05, ηp2 = 0.14 | |
Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean ± at pre and post training sessions using POMj and PLA supplementations.
Significant differences between pre-post training sessions.
P Significant differences between POMj and PLA values at pre training sessions (i.e., 48h recovery).
Effect of 48h of recovery period associated to PLA supplementation in the biological responses.
| Variables | Placebo | Δ 48h-3’ in % | ANOVA | ||
|---|---|---|---|---|---|
| 3’Post training | 48h recovery | Rest values | |||
| 37.03±0.45 | 36.14±0.69 | 36.18±0.69 | -02.39% | ||
| 86.56±8.60 | 72.44±9.00 | 69.78±9.74 | -16.04% | ||
| 13.44±0.56 | 12.49±0.96 | 12.17±0.90 | -07.19% | ||
| 05.08± 0.59 | 05.02±0.50 | 04.88±0.48 | NS | F = 0.74, p>0.05, ηp2 = 0.1 | |
| 83.56±8.23 | 82.00±8.26 | 83.44±9.18 | NS | F = 2.98, p>0.05, ηp2 = 0.1 | |
| 07.77±2.11 | 08.62±2.67 | 08.17±2.25 | +10.82% | ||
| 04.99±1.41 | 05.34±2.12 | 05.19±1.68 | NS | F = 0.71, p>0.05, ηp2 = 0.1 | |
| 05.90±0.62 | 06.08±0.54 | 05.73±0.63 | NS | F = 1.99, p>0.05, ηp2 = 0.1 | |
| 196.8±37.1 | 162.11±38.2 | 181.9±46.0 | -16.07% | ||
| 451.2±55.8 | 342.4±42.2 | 237.4±36.5 | -23.98% | ||
| 197.2±40.1 | 169.7±24.9 | 145.3±18.2 | -12.97% | ||
| 30.77±7.59 | 26.11±7.61 | 20.11±3.82 | -14.70% | ||
| 70.67±12.9 | 72.44±13.5 | 73.22±16.0 | NS | F = 2.16, p>0.05, ηp2 = 0.2 | |
| 01.46±0.90 | 01.39±0.91 | 01.24±0.70 | NS | F = 2.87, p>0.05, ηp2 = 0.7 | |
Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean ± at rest, 3min and 48h post training session using PLA supplementations.
A Significant differences between 48h and 3min post training session.
B Significant difference between 48h recovery and rest values. NB: 3’ Post training correspond to blood sample 1, 48h recovery correspond to blood sample 2 and rest correspond to blood sample 6
Effect of 48h of recovery period associated to POMj supplementation in the biological responses.
| Variables | Pomegranate | Δ 48h-3’ in % | ANOVA | ||
|---|---|---|---|---|---|
| 3’Post training | 48h recovery | Rest values | |||
| 36.98±0.51 | 36.06±0.82 | 36.18±0.69 | -02.49% | ||
| 85.11±10.6 | 70.78±9.64 | 69.78±9.74 | -16.60% | ||
| 13.67±0.35 | 11.59±0.37 | 12.16±0.90 | -15.16% | ||
| 05.05±0.59 | 04.80±0.41 | 04.88±0.48 | NS | F = 1.24, p>0.05, ηp2 = 0.1 | |
| 83.67±9.43 | 82.11±8.75 | 83.44±9.18 | NS | F = 0.73, p>0.05, ηp2 = 0.1 | |
| 07.52±2.03 | 08.36±2.19 | 08.17±2.25 | +11.42% | ||
| 04.87±1.86 | 04.83±1.90 | 05.19±1.68 | NS | F = 2.67, p>0.05, ηp2 = 0.1 | |
| 05.43±0.41 | 05.51±0.59 | 05.73±0.63 | NS | F = 1.85, p>0.05, ηp2 = 0.1 | |
| 200.3±42. 9 | 184.1±43.6 | 181.9±46.0 | NS | F = 1.68, p>0.05, ηp2 = 0.1 | |
| 440.3±56.2 | 262.1±19.6 | 237.4±36.5 | -35.32% | ||
| 198.3±43.9 | 156.0±23.3 | 145.3±18.2 | -20.27% | ||
| 30.44±9.33 | 23.33±5.29 | 20.11±3.82 | -21.47% | ||
| 75.76±14.1 | 72.78±16.4 | 73.22±16.0 | NS | F = 2.81, p>0.05, ηp2 = 0.1 | |
| 01.48±0.91 | 01.30±0.88 | 01.24±0.70 | NS | F = 2.69, p>0.05, ηp2 = 0.1 | |
Temperature, Heart rate (HR), Systolic blood pressure (SBP), Blood Glucose (GLC), Creatinine (CRE), White blood cells (WBC), Neutrophils (NEU), Red blood cells (RBC), Platelets (PLT), Creatinine kinase (CK), Lactate dehydrogenase (LDH), Aspartate aminotransferase (ASAT), Alkaline phosphate (PAL) and C-reactive protein (CRP) represented as mean ± at rest, 3min and 48h post training session using PLA supplementations.
A Significant differences between 48h and 3min post training session.; NB: 3’ Post training correspond to blood sample 1, 48h recovery correspond to blood sample 2 and rest correspond to blood sample 6